Archives

by in
Entry Author Date Location
Cardeas Gears Up for Clinic, With Drug Combo for Hospital Infections 04/26/12 Seattle
InDi, Lee Hood’s Vision for Spotting Cancer in Blood, Snags $10M 02/22/12 Seattle
Bruce Montgomery’s New Startup, Cardeas Pharma, Raises $5M 12/20/11 Seattle
Thong Le Named New Chairman of WBBA, Replacing Tom Clement 10/07/11 Seattle
Calistoga Hands the Keys to Gilead, Bets It Can Make Cancer a Chronic Disease Like HIV 02/23/11 Seattle
Montgomery Startup Gets $1M 02/22/11 Seattle
Geospiza Adds Montgomery to Board 10/19/10 Seattle
Seattle Doesn’t Need a Biotech Anchor Tenant. It Needs to Be a Place Where Startups Thrive 09/14/10 Seattle
Gilead’s Lung Drug Ace, Bruce Montgomery, Hits Free Agent Market, Scopes Startup Ideas 08/05/10 Seattle
Genentech’s Souped-Up Antibody, Reg Kelly’s Mission, LS9 Nears Moment of Truth & More Bay Area Life Sciences News 06/25/10 San Francisco
Seattle Genetics’ Dark Horse, Gilead Beats Novartis, Oncothyreon Back in the Saddle, & More Seattle-Area Life Sciences News 06/24/10 Seattle
Biotech Drug Discovery in Seattle: A Look Back 06/11/10 Seattle
Dendreon Spending Big Bucks, Gilead Gets FDA Nod, NanoString Thinking Diagnostics, & More Seattle-Area Life Sciences News 02/25/10 Seattle
Gilead Sciences Gets FDA Green Light To Sell Cystic Fibrosis Drug 02/23/10 Seattle
VentiRx Nabs $25M, Gilead Deepens Seattle Roots, Sage Strikes Deal With Pfizer & More Seattle-Area Life Sciences News 01/14/10 Seattle
Dendreon Nails Down $409M, Stewart Parker Gets Itch to Return, Seattle Genetics Finds New Partner, & More Seattle-Area Life Sciences News 12/17/09 Seattle
Gilead Cystic Fibrosis Drug Gets Green Light From FDA Panel 12/10/09 Seattle
EU Spurns Gilead’s Aztreonam 03/20/09 Seattle
Invest Northwest Notebook: Five of Seattle’s Next-Generation Life Sciences Innovators Seek to Adapt 03/19/09 Seattle
Traditional Venture Model is “Broken” for Biotech, Companies Need to Adapt, Says VC Alan Frazier 12/04/08 Seattle
WRF Capital, With Clock Ticking on Expiring Patents, Aims to Build Sustained Venture Fund 10/20/08 Seattle
Gilead Drug For Cystic Fibrosis Fails to Win FDA Approval 09/16/08 Seattle
Gilead’s Seattle Crew Awaits FDA Clearance of Cystic Fibrosis Drug, Catalyst for Future Growth 09/15/08 Seattle
Page 1 of 1